Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -0.29 |
peg ratio | -0.02 |
price to book ratio | 0.98 |
price to sales ratio | 0.77 |
enterprise value multiple | 0.25 |
price fair value | 0.98 |
profitability ratios | |
---|---|
gross profit margin | 72.5% |
operating profit margin | -337.8% |
pretax profit margin | -117.52% |
net profit margin | -263.31% |
return on assets | -51.18% |
return on equity | -122.55% |
return on capital employed | -167.1% |
liquidity ratio | |
---|---|
current ratio | 0.85 |
quick ratio | 0.74 |
cash ratio | 0.31 |
efficiency ratio | |
---|---|
days of inventory outstanding | 463.85 |
operating cycle | 640.67 |
days of payables outstanding | 528.31 |
cash conversion cycle | 112.36 |
receivables turnover | 2.06 |
payables turnover | 0.69 |
inventory turnover | 0.79 |
debt and solvency ratios | |
---|---|
debt ratio | 0.35 |
debt equity ratio | 2.33 |
long term debt to capitalization | 0.61 |
total debt to capitalization | 0.70 |
interest coverage | -26.17 |
cash flow to debt ratio | -0.80 |
cash flow ratios | |
---|---|
free cash flow per share | -0.59 |
cash per share | 0.40 |
operating cash flow per share | -0.59 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -0.80 |
short term coverage ratios | -2.51 |
capital expenditure coverage ratio | -2,914,175.00 |
Frequently Asked Questions
Petros Pharmaceuticals, Inc. (PTPI) published its most recent earnings results on 13-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Petros Pharmaceuticals, Inc. (NASDAQ:PTPI)'s trailing twelve months ROE is -122.55%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Petros Pharmaceuticals, Inc. (PTPI) currently has a ROA of -51.18%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
PTPI reported a profit margin of -263.31% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.85 in the most recent quarter. The quick ratio stood at 0.74, with a Debt/Eq ratio of 2.33.